Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
08 06 2021
Historique:
received: 06 09 2020
revised: 28 01 2021
accepted: 30 03 2021
pubmed: 5 5 2021
medline: 15 9 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1s) are heterogenous innate lymphocytes broadly defined in mice as Lin

Identifiants

pubmed: 33945787
pii: S1074-7613(21)00136-9
doi: 10.1016/j.immuni.2021.03.024
pmc: PMC8312473
mid: NIHMS1692687
pii:
doi:

Substances chimiques

NK Cell Lectin-Like Receptor Subfamily B 0
Natural Cytotoxicity Triggering Receptor 1 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1320-1337.e4

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK124699
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK077653
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR066551
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE025884
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA235096
Pays : United States
Organisme : Dutch Research Council
ID : NWO_019.181EN.038
Pays : Netherlands
Organisme : NIAID NIH HHS
ID : R01 AI134035
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI134236
Pays : United States
Organisme : NIDDK NIH HHS
ID : F30 DK127540
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of interests M.C. receives research support from Pfizer and NGM Biopharmaceuticals, is a scientific advisory board member of Vigil Neuroscience and NGM Biopharmaceuticals, and is a consultant of Cell Signaling Technologies. I.A. is a scientific advisory board member of Neogene Therapeutics and CELLINK.

Références

Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
Crit Rev Immunol. 2016;36(2):131-147
pubmed: 27910764
Science. 2016 Apr 22;352(6284):459-63
pubmed: 27102484
Life Sci. 2002 Jan 4;70(7):791-8
pubmed: 11833741
Science. 2014 Feb 14;343(6172):776-9
pubmed: 24531970
Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents
pubmed: 19721090
J Immunol. 2013 Aug 1;191(3):1486-95
pubmed: 23817426
Immunity. 2019 Apr 16;50(4):1054-1068.e3
pubmed: 30926235
Nature. 2014 Apr 17;508(7496):397-401
pubmed: 24509713
Nature. 2018 Jul;559(7713):264-268
pubmed: 29973721
J Steroid Biochem Mol Biol. 2016 Mar;157:48-60
pubmed: 25917081
Sci Rep. 2015 Nov 05;5:16269
pubmed: 26537633
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
Science. 2016 Oct 28;354(6311):481-484
pubmed: 27708054
Cell. 2015 Dec 3;163(6):1444-56
pubmed: 26638073
Immunity. 2010 Aug 27;33(2):229-40
pubmed: 20727791
Immunity. 2016 May 17;44(5):1127-39
pubmed: 27156386
Immunity. 2020 Jan 14;52(1):96-108.e9
pubmed: 31810881
Front Immunol. 2014 Apr 02;5:145
pubmed: 24765094
Cell. 2017 Nov 2;171(4):795-808.e12
pubmed: 29056343
Cell. 2020 Feb 20;180(4):813-814
pubmed: 32084342
Nat Immunol. 2016 Jun 21;17(7):765-74
pubmed: 27328006
Nat Protoc. 2019 Jun;14(6):1841-1862
pubmed: 31101904
Immunity. 2018 Jun 19;48(6):1104-1117
pubmed: 29924976
Immunity. 2014 Sep 18;41(3):354-365
pubmed: 25238093
Immunity. 2018 Nov 20;49(5):971-986.e5
pubmed: 30413361
Mol Cell Biol. 2004 Jul;24(13):5767-75
pubmed: 15199133
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15247-52
pubmed: 16217040
J Exp Med. 2015 Nov 16;212(12):2015-25
pubmed: 26503444
Immunol Rev. 2017 Nov;280(1):93-101
pubmed: 29027233
Dis Model Mech. 2015 Mar;8(3):237-51
pubmed: 25633981
Nature. 2012 Aug 9;488(7410):222-5
pubmed: 22801499
BMC Bioinformatics. 2018 Dec 7;19(1):470
pubmed: 30526489
Cell. 2019 Jan 10;176(1-2):348-360.e12
pubmed: 30595449
Nat Immunol. 2019 Aug;20(8):980-991
pubmed: 31209406
Curr Opin Immunol. 2015 Feb;32:71-7
pubmed: 25615701
Genome Biol. 2019 Oct 11;20(1):206
pubmed: 31604482
Cell Rep. 2017 Jul 18;20(3):613-626
pubmed: 28723565
Immunity. 2020 Jun 16;52(6):1075-1087.e8
pubmed: 32445619
Immunol Lett. 2016 Nov;179:19-24
pubmed: 27394699
PLoS One. 2009 Nov 13;4(11):e7830
pubmed: 19915675
J Immunol. 2009 Sep 1;183(5):2911-4
pubmed: 19648279
J Exp Med. 2014 Mar 10;211(3):563-77
pubmed: 24516120
J Immunol. 2011 Sep 1;187(5):2067-71
pubmed: 21795595
Immunity. 2019 Feb 19;50(2):505-519.e4
pubmed: 30770247
Nat Immunol. 2015 Mar;16(3):306-17
pubmed: 25621825
Mol Med Rep. 2015 Nov;12(5):6399-404
pubmed: 26324337
Immunity. 2016 Jan 19;44(1):103-115
pubmed: 26795246
Int Rev Immunol. 2016 Jul 3;35(4):325-339
pubmed: 25259408
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Elife. 2014 Jan 01;3:e01659
pubmed: 24714492
Front Immunol. 2016 Jan 07;6:646
pubmed: 27004067
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5370-5
pubmed: 27114551
Science. 2015 May 22;348(6237):aaa6566
pubmed: 25999512
Nat Immunol. 2016 Jun 21;17(7):775-82
pubmed: 27328007
Nat Commun. 2018 Oct 29;9(1):4492
pubmed: 30374017
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3378-83
pubmed: 17360654
Immunity. 2018 Jun 19;48(6):1172-1182.e6
pubmed: 29858012
Nature. 2013 Feb 14;494(7436):261-5
pubmed: 23334414
Mol Cell Biol. 1992 Mar;12(3):954-61
pubmed: 1312220
Immunol Rev. 2018 Nov;286(1):23-36
pubmed: 30294970
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Cell Rep. 2018 Feb 20;22(8):2107-2117
pubmed: 29466737
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
J Immunol. 2016 Feb 15;196(4):1449-54
pubmed: 26792802
Nat Rev Immunol. 2018 Jan;18(1):35-45
pubmed: 28787399
Immunity. 2012 Jan 27;36(1):55-67
pubmed: 22261438
Nat Immunol. 2020 Aug;21(8):835-847
pubmed: 32690952
Nat Immunol. 2017 Sep;18(9):1004-1015
pubmed: 28759001
Immunol Rev. 2006 Dec;214:35-46
pubmed: 17100874
Cell Signal. 2011 Aug;23(8):1375-86
pubmed: 21447383
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Immunity. 2019 Jul 16;51(1):104-118.e7
pubmed: 31128961
J Immunol. 2006 Jun 1;176(11):7028-38
pubmed: 16709865
Front Immunol. 2019 Sep 24;10:2278
pubmed: 31616440

Auteurs

Adelle P McFarland (AP)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Adam Yalin (A)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Shuang-Yin Wang (SY)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Victor S Cortez (VS)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Tomer Landsberger (T)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Raki Sudan (R)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Vincent Peng (V)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Hannah L Miller (HL)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Biancamaria Ricci (B)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Eyal David (E)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Roberta Faccio (R)

Department of Orthopedics, Washington University School of Medicine, St. Louis, MO, USA; Shriners Children's Hospital in St. Louis, St. Louis, MO, USA.

Ido Amit (I)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel. Electronic address: ido.amit@weizmann.ac.il.

Marco Colonna (M)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: mcolonna@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH